Altered MicroRNA Profile in Osteoporosis Caused by Impaired WNT Signaling
Author(s) -
Riikka E. Mäkitie,
Matthias Hackl,
Riitta Niinimäki,
Sakari Kakko,
Johannes Grillari,
Outi Mäkitie
Publication year - 2018
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2017-02585
Subject(s) - wnt signaling pathway , missense mutation , microrna , mutation , osteoporosis , lrp5 , medicine , biology , cancer research , endocrinology , bioinformatics , signal transduction , genetics , gene
WNT signaling is fundamental to bone health, and its aberrant activation leads to skeletal pathologies. The heterozygous missense mutation p.C218G in WNT1, a key WNT pathway ligand, leads to severe early-onset and progressive osteoporosis with multiple peripheral and spinal fractures. Despite the severe skeletal manifestations, conventional bone turnover markers are normal in mutation-positive patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom